We are live on
!
Find out more
DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
1-Year Est. Return
29.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$109K
(-0.07%)
Cap. Flow
-$7.01M
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
76
New
12
Increased
23
Reduced
29
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.02M |
| 2 |
Canadian Solar
CSIQ
|
+$2.54M |
| 3 |
Ulta Beauty
ULTA
|
+$2.21M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.6M |
| 5 |
AbbVie
ABBV
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$2.79M |
| 2 |
Texas Instruments
TXN
|
+$2.45M |
| 3 |
Amgen
AMGN
|
+$2.42M |
| 4 |
HAR
Harman International Industries
HAR
|
+$2.32M |
| 5 |
Tyson Foods
TSN
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.3% |
| 2 | Financials | 15.77% |
| 3 | Technology | 11.18% |
| 4 | Communication Services | 8.59% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Palo Alto Networks
PANW
$297B
| $1.44M | 0.86% |
49,290
-13,410
| -21% | -$358K |
|
52
Starbucks
SBUX
$120B
| $1.42M | 0.86% |
+26,530
| New | +$1.35M |
|
53
Sanofi
SNY
$104B
| $1.37M | 0.83% |
27,675
-1,255
| -4% | -$63.6K |
|
|
NFX
54
DELISTED
Newfield Exploration
NFX
| $1.34M | 0.81% |
37,135
+1,800
| +5% | +$67K |
|
55
Ameriprise Financial
AMP
$48.8B
| $858K | 0.52% |
+6,865
| New | +$875K |
|
|
TW
56
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $843K | 0.51% |
+6,700
| New | +$899K |
|
57
EOG Resources
EOG
$70.7B
| $447K | 0.27% |
5,100
+15
| +0.3% | +$1.39K |
|
58
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$705M
| $344K | 0.21% |
+8,230
| New | +$355K |
|
59
Sony
SONY
$138B
| $331K | 0.2% |
+58,300
| New | +$357K |
|
|
JKS
60
JinkoSolar
JKS
$891M
| $325K | 0.2% |
+11,020
| New | +$320K |
|
61
iShares China Large-Cap ETF
FXI
$4.31B
| $304K | 0.18% |
+6,600
| New | +$327K |
|
62
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $291K | 0.18% |
+9,440
| New | +$308K |
|
63
Prudential
PUK
$35.2B
| $286K | 0.17% |
6,073
-783
| -11% | -$38K |
|
|
SHPG
64
DELISTED
Shire pic
SHPG
| $283K | 0.17% |
1,170
| – | – |
|
65
Liberty Global Class C
LBTYK
$3.49B
| $202K | 0.12% |
+4,926
| New | +$204K |
|
66
AstraZeneca
AZN
$250B
| – | – |
-27,120
| Closed | -$1.86M |
|
|
67
Chubb
CB
$135B
| – | – |
-25,002
| Closed | -$2.79M |
|
68
ProShares UltraShort Euro
EUO
$34.6M
| – | – |
-13,322
| Closed | -$359K |
|
69
Micron Technology
MU
$991B
| – | – |
-21,045
| Closed | -$571K |
|
70
Puma Biotechnology
PBYI
$454M
| – | – |
-3,180
| Closed | -$751K |
|
|
71
Tyson Foods
TSN
$20.4B
| – | – |
-49,275
| Closed | -$1.89M |
|
|
72
Texas Instruments
TXN
$261B
| – | – |
-42,795
| Closed | -$2.45M |
|
|
WBA
73
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-2,865
| Closed | -$243K |
|
|
ALXN
74
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-5,020
| Closed | -$870K |
|
|
HAR
75
DELISTED
Harman International Industries
HAR
| – | – |
-17,350
| Closed | -$2.32M |
|
Similar funds
LOT
BGA
PCM
EDRAML
EC
SAMNY
BCCM
EIAM
DG Capital Management (Massachusetts)'s Q2 2015 Portfolio in Review
As of Q2 2015, DG Capital Management (Massachusetts) held 76 positions worth $166M, down 0.07% from $166M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
DG Capital Management (Massachusetts) withdrew a net $7.01M in Q2 2015, closing 11 positions and reducing 29 holdings. Its most notable exit was Chubb, an estimated $2.79M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Financials and Technology.
Against the trend, DG Capital Management (Massachusetts) opened a new position in BioMarin Pharmaceuticals worth $3.33M.
- DG Capital Management (Massachusetts)'s largest Q2 2015 buy was BioMarin Pharmaceuticals: 24,345 shares worth $3.33M.
- DG Capital Management (Massachusetts) added most to Bristol-Myers Squibb in Q2 2015, an estimated $1.6M increase.
- DG Capital Management (Massachusetts)'s biggest Q2 2015 reduction was Amgen, cutting an estimated $2.42M.
- DG Capital Management (Massachusetts) fully exited Chubb in Q2 2015, selling an estimated $2.79M.
- DG Capital Management (Massachusetts)'s ten largest holdings make up 30% of its $166M portfolio in Q2 2015.
- DG Capital Management (Massachusetts) opened 12 new positions and closed 11 in Q2 2015.
- DG Capital Management (Massachusetts)'s portfolio value fell 0.07% quarter-over-quarter to $166M.
Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2015, filed 11 Aug 2015.